EAM
NVAX icon

EverPoint Asset Management’s Novavax NVAX Stock Holding History

EverPoint Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-80,000
Closed -$11.6M – 475
2016
Q2 		$11.6M Buy
80,000
+70,000
+700% +$8.02M 0.23% 128
2016
Q1 		$1.03M Buy
+10,000
New +$1.07M 0.02% 381

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EverPoint Asset Management's NVAX Position: Q2 2015 in Review

EverPoint Asset Management sold out of Novavax (NVAX) in Q2 2015, closing a stake of 20,000 shares — an estimated $3.31M sold.

EverPoint Asset Management first reported a position in NVAX in Q1 2015 and held it in 1 quarter. The position peaked at $3.31M in Q1 2015. 159 funds tracked by Wall St. Rank hold NVAX as of Q2 2015.

  • EverPoint Asset Management reported no remaining Novavax position as of Q2 2015 after selling out during the quarter.
  • EverPoint Asset Management sold 20,000 Novavax shares in Q2 2015, an estimated $3.31M.
  • EverPoint Asset Management first reported a position in Novavax in Q1 2015 and held it in 1 quarter.
  • EverPoint Asset Management's Novavax position peaked at $3.31M in Q1 2015.
  • 159 funds tracked by Wall St. Rank held Novavax as of Q2 2015.

Based on EverPoint Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.